MULTI DOSE DRUG VIAL ADAPTERS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Market Concentration and Competitive Landscape

Close-monitor your Competitor's Move, Request sample copy

The healthcare industry has seen a significant rise in self-administration of drugs and usage of home healthcare devices in recent years. This has been mainly driven by the convenience offered to patients and the reduction in hospital visits. As patients and caregivers are conducting more medical procedures at home, the need for adapters that can be used with multi-dose vials for self-injections or attachment with home healthcare devices has risen substantially. Multi-dose drug vial adapters provide a sterile barrier between the vial and the injection mechanism, preventing contamination. They help withdraw multiple doses from the vial for administration without touching the vial septum directly. This brings more safety and hygienic drug delivery. With growing preference for home treatment systems among patients with chronic diseases like diabetes, arthritis, etc., the demand for such adapters has surged rapidly. The COVID-19 pandemic has further accelerated this transition to home healthcare delivery. Hospital visits were restricted during pandemic peaks to avoid infections for non-critical cases. This pushed more treatment loads to home settings. Many patients continue preferring self-administration in the comfort of their homes even after pandemic restrictions are lifted. All these factors are expected to propel the multi dose drug vial adapters market even stronger in the future.

• BD
• B. Braun SE
• Terumo Medical Corporation
• Adelphi Group
• Med-Vet International
• West Pharmaceutical Services, Inc.
• ICU Medical
• Helapet Ltd.
• Sartorius AG
• Thermo Fisher Scientific Inc.
• Miltenyi Biotec
• Randox Laboratories Ltd. 
• West Pharmaceutical Services, Inc.
• Amsino International, Inc.
• Medline Industries, LP.